Cybin (CYBN.NE) receives conditional approval to list on the NYSE Post date July 22, 2021 Posted by Piers Eaton Posted in American Exchanges, Biotech, cybin, CYBN, CYBN.NE, Eaton, Health Science, Mushrooms, Nasdaq, NYSE, NYSE American, OTCQB, Psychedelics, Scribes, Uplisting Comments 0